Latest News about PFE
Recent news which mentions PFE
From Benzinga
From Benzinga
Hypocrisy All Around: Pfizer, NFL Are Hidden Sponsors Of Anti-Drug Group Fighting Against Cannabis Legalization
August 17, 2022
From Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
August 17, 2022
From Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
August 17, 2022
From InvestorPlace
Has Moderna Made a Bear Market Blunder?
August 17, 2022
From Motley Fool
From MarketWatch
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2022
From Benzinga
U.K. regulator is first to authorize Moderna’s bivalent COVID booster for adults aged 18 and older
August 15, 2022
From MarketWatch
1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)
August 15, 2022
From Motley Fool
Landmark Drug Pricing Reform Bill Passes Congress House
August 15, 2022
From Benzinga
Here's How This Beaten-Down Stock Could 10X by 2024
August 13, 2022
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 12, 2022
From Benzinga
Pfizer Shares Ascend Following Positive Data From Late-Stage Pneumococcal Vaccine Trial For Infants
August 12, 2022
Tickers
PFE
From Benzinga
GSK defends Zantac ahead of trials that have cratered the stock
August 12, 2022
From MarketWatch
Why Pfizer Stock Slipped Today
August 11, 2022
From Motley Fool
4 Dividend Stocks Set to Move Significantly Higher This Year
August 11, 2022
From InvestorPlace
McDonald’s set to reopen in some cities in Ukraine: Report
August 11, 2022
From MarketWatch
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
August 11, 2022
From Benzinga
GSK, PFE, SNY Stocks Fall on Zantac Litigation
August 11, 2022
From InvestorPlace
Deciphera's Cancer Drug Tops Pfizer's Sutent On Safety Front In Gastrointestinal Cancer
August 11, 2022
From Benzinga
From Benzinga
From Motley Fool
4 Index Funds to Retire a Millionaire Without Lifting a Finger
August 11, 2022
From Motley Fool
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
August 10, 2022
From Motley Fool
10 defensive stocks that can also provide you with growth and dividends over the long term
August 10, 2022
From MarketWatch
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US
August 09, 2022
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.